Neonatal Mortality and Long-Term Outcome of Infants Born between 27 and 32 Weeks of Gestational Age in Breech Presentation: The EPIPAGE Cohort Study by Azria, Elie et al.
Neonatal Mortality and Long-Term Outcome of Infants
Born between 27 and 32 Weeks of Gestational Age in
Breech Presentation: The EPIPAGE Cohort Study
Elie Azria, Gilles Kayem, Bruno Langer, Laetitia Marchand-Martin, Stephane
Marret, Jeanne Fresson, Ve´ronique Pierrat, Catherine Arnaud, Franc¸ois
Goffinet, Monique Kaminski, et al.
To cite this version:
Elie Azria, Gilles Kayem, Bruno Langer, Laetitia Marchand-Martin, Stephane Marret, et al..
Neonatal Mortality and Long-Term Outcome of Infants Born between 27 and 32 Weeks of
Gestational Age in Breech Presentation: The EPIPAGE Cohort Study. PLoS ONE, Public
Library of Science, 2016, 11 (1), pp.e0145768. <10.1371/journal.pone.0145768.t005>. <hal-
01270729>
HAL Id: hal-01270729
http://hal.upmc.fr/hal-01270729
Submitted on 8 Feb 2016
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
Distributed under a Creative Commons Attribution 4.0 International License
RESEARCH ARTICLE
Neonatal Mortality and Long-Term Outcome
of Infants Born between 27 and 32 Weeks of
Gestational Age in Breech Presentation: The
EPIPAGE Cohort Study
Elie Azria1,2*, Gilles Kayem1,2,3, Bruno Langer4, Laetitia Marchand-Martin1,
Stephane Marret5,6, Jeanne Fresson1,2,3,4,5,6,7, Véronique Pierrat1,2,3,4,5,6,7,8,
Catherine Arnaud9,10, François Goffinet1,2,3,4,5,6,7,8,9,10,11, Monique Kaminski1, Pierre-
Yves Ancel1, EPIPAGE study group¶
1 INSERM, U-1153, Epidemiology and Biostatistics Sorbonne Paris Cité Center, Obstetrical, Perinatal and
Pediatric Epidemiology Team, DHU Risk in Pregnancy, Paris, France, 2 Department of Obstetrics, Groupe
Hospitalier Paris Saint Joseph, Paris Descartes University, Paris, France, 3 Department of Obstetrics and
Gynecology, Hôpital Trousseau, Assistance Publique des Hôpitaux de Paris, University Pierre et Marie
Curie, Paris, France, 4 Department of Gynecology Obstetrics, Strasbourg University Hospitals, Hôpital de
Hautepierre, Strasbourg, France, 5 Department of Neonatal Medicine, Rouen University Hospital, Rouen,
France, 6 INSERM, AVENIR Research Group & Department of Neonatal Medicine and Intensive Care and
Regional Center for Diagnosis and Research on Developmental Language and Behavioural Disorders,
Rouen Institute for Biomedical Research, Rouen, France, 7 Medical Information Department, Regional
Maternity University Hospital, Nancy, France, 8 Department of Neonatal Medicine, Hôpital Jeanne de
Flandre, Lille, France, 9 INSERM, UMR 1027 Inserm, Toulouse III University, F-31000, Toulouse, France,
10 Clinical epidemiology unit, University Hospital, F-31000, Toulouse, France, 11 Department of Obstetrics
and Gynecology, Port-Royal Maternity, Groupe Hospitalier Cochin-Broca-Hôtel Dieu, Assistance Publique
des Hôpitaux de Paris, Paris, France
¶ The complete membership of the EPIPAGE study group can be found in the acknowledgments.
* eazria@hpsj.fr
Abstract
Objective
To determine whether breech presentation is an independent risk factor for neonatal mor-
bidity, mortality, or long-term neurologic morbidity in very preterm infants.
Design
Prospective population-based cohort.
Population
Singletons infants without congenital malformations born from 27 to 32 completed weeks of
gestation enrolled in France in 1997 in the EPIPAGE cohort.
Methods
The neonatal and long-term follow-up outcomes of preterm infants were compared between
those in breech presentation and those in vertex presentation. The relation of fetal
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presentation with neonatal mortality and neurodevelopmental outcomes was assessed
using multiple logistic regression models.
Results
Among the 1518 infants alive at onset of labor included in this analysis (351 in breech pre-
sentation), 1392 were alive at discharge. Among those eligible to follow up and alive at 8
years, follow-up data were available for 1188 children. Neonatal mortality was significantly
higher among breech than vertex infants (10.8% vs. 7.5%, P = 0.05). However the differ-
ences were not significant after controlling for potential confounders. Neonatal morbidity did
not differ significantly according to fetal presentation. Severe cerebral palsy was less fre-
quent in the group born in breech compared to vertex presentation but there was no differ-
ence after adjustment. There was no difference according to fetal presentation in cognitive
deficiencies/learning disabilities or overall deficiencies.
Conclusion
Our data suggest that breech presentation is not an independent risk factor for neonatal
mortality or long-term neurologic deficiencies among very preterm infants.
Introduction
Poorer outcomes have been reported for term infants in breech compared with vertex presenta-
tion [1–3]. These may result either from underlying conditions that might cause breech presen-
tation, such as congenital anomalies [4] or intrauterine growth restriction, or from perinatal
complications during labor[5] and delivery [6]. Some authors [3,7], but not all [8,9] consider
that breech presentation is an independent risk factor for neonatal morbidity and mortality for
term newborns.
The question of outcome according to presentation at birth also arises for preterm infants.
Preterm birth is associated with a higher prevalence of breech presentation. The frequency of
breech deliveries decreases as gestational age increases and affects approximately 3–4% of all
term infants. Scheer and Nubar reported a prevalence of breech presentation ranging from 9%
at 33 to 36 weeks gestation to 28% at 25 to 28 weeks [10].
It has been suggested that neonatal mortality in preterm infants might be independently
associated with breech presentation [11,12]. This idea, however, is based on studies subject to
bias and relies on old data that might not reflect current clinical practices. To our knowledge, no
published study has compared the long-term morbidity, especially neurocognitive deficiencies,
of preterm infants according to their presentation—breech or vertex. Such a study would require
a large sample size, specific developmental assessments, and long-term follow up. It is therefore
not known if breech presentation is really an independent risk factor in preterm infants for neo-
natal mortality and for short- and long-term morbidity or if the suggested increased risk is due
to other factors, such as the underlying condition of the fetus or the mode of delivery [13].
The purpose of this study is to compare the outcomes of very preterm infants according to
whether they were born in breech or vertex presentation and thereby determine whether
breech presentation is an independent risk factor for neonatal mortality and morbidity and for
long-term neurologic morbidity in this population. For this study, we used the data of a large
prospective cohort of very preterm infants born in 1997 and followed up to the age of 8 years.
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Methods
Population study
The EPIPAGE (Etude EPIdémiologique sur les Petits Ages Gestationnels, epidemiologic study
of early gestation ages) study is a population-based prospective cohort study that included all
births occurring from 22 to 32 completed weeks of gestation in 1997 in 9 French regions. It has
been described in detail elsewhere [14]. At recruitment in the maternity or neonatal unit,
parents were told about the study and given written information. Verbal consent was provided
to the local teams in charge of the study. The study was approved by the French Commission
Nationale de l'Informatique et des Libertés (the French data protection agency).
Although all infants born before 33 weeks were enrolled in the EPIPAGE cohort, we chose
to restrict this analysis to those born at 27–32 weeks in order to avoid the wide variability of
obstetric and neonatal care practices before 27 weeks [15,16]. This study was also restricted to
singletons and to infants alive at onset of labor or before delivery when cesarean delivery was
decided before labor. Moreover, infants were excluded if they had a congenital malformation
identified as severe independently by two obstetricians (EA and GK) or were born in a nonver-
tex nonbreech presentation, or had missing data for presentation.
Maternal and perinatal characteristics
Neonatal and obstetric data were extracted from medical records, and social characteristics
were collected by maternal interview. Socioeconomic status (SES) was recorded according to
the French classification of occupations and social position and grouped into five categories.
Family SES was defined as the highest of the mother or father’s occupation, or if she lived
alone, the mother’s occupation. Maternal age, country of birth, and education level were also
recorded.
Medical information included previous and current obstetric history. Fetal presentation,
antenatal administration of corticosteroids, mode of delivery grouped in 3 categories (vaginal
birth, cesarean section during labor, cesarean section before labor), gestational age at delivery,
and infant sex were considered. The obstetric complications leading to the preterm birth were
recorded and grouped in 4 categories: 1- maternal hypertension or small-for-gestational-age
fetus (SGA), defined as birth weight10th percentile (EPIPAGE internal reference) [17]; 2-
spontaneous preterm labor or PPROM (preterm premature rupture of the membranes); 3- pla-
centa praevia, abruptio placentae, or other hemorrhage; 4- other. The level of maternity unit
facilities was recorded. In 1997 in France there were no national guidelines for the management
of preterm infant in breech presentation delivery.
Neonatal outcomes
Neonatal outcomes included death (including intrapartum death, death in the maternity unit
or in the neonatal unit), called "neonatal death" in the text and tables, early-onset neonatal
infection (confirmed infection of maternal origin), and late-onset neonatal infections (post-
natally acquired infection treated with antibiotics for at least 7 days) as defined by Mitha et al
[18], necrotizing enterocolitis, bronchopulmonary dysplasia (O2 dependency at 36 weeks),
and neonatal cerebral lesions on neonatal cranial ultrasound, classified as major (cystic peri-
ventricular leukomalacia or intraparenchymal hemorrhage), moderate (intraventricular
hemorrhage with primary ventricular dilatation (IVH) or ventricular dilatation or persistent
echodensity), minor (subependymal hemorrhage or IVH without ventricular dilatation), or
no lesions.
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PLOS ONE | DOI:10.1371/journal.pone.0145768 January 8, 2016 3 / 14
Neurodevelopmental outcomes
The main steps of the follow-up included: 1) a standardized medical examination completed
by the child’s treating physician at 2 years of age; 2) a standardised medical examination,
including a short version of the Touwen neurologic examination [19] and a developmental
assessment with the Kaufman Assessment Battery for Children (K- ABC) [20], at 5 years of
age, performed by trained examiners in special centers set up for the study [14,21]; data on spe-
cial care were also collected; 3) a postal questionnaire, sent to parents to investigate the child’s
health and school situation at 8 years of age. Moreover, in 5 regions, a questionnaire was com-
pleted with the local office for people with disabilities (Maison Départementale des Personnes
Handicapées) in 5 regions, to collect information on deficiencies, special schooling, and special
care. All available information from all follow-up points was used to identify children with neu-
romotor, cognitive, neurosensory, or psychiatric deficiencies. Priority in grading severity was
given to the most recent information. The methods and detailed classifications have been
described in detail elsewhere [22]. Table 1 shows the main categories of deficiencies studied, ie
neuromotor and cognitive.
As explained previously in the Marret et al. paper [22], to reduce bias due to loss to follow-
up and to be able to classify as many children as possible, we used all available data from all
stages of follow-up (2, 5, and 8 years) for each deficiency to determine if it affected the child
and how severely. Moreover, when information in one domain of development was missing at
one stage of follow up, the child was considered free from this deficiency at that stage.
Statistical analysis
Children in breech presentation at birth were compared to those in vertex presentation for the
obstetric complication leading to the birth, mortality, neonatal morbidity, and long-term neu-
rodevelopmental outcomes.
The comparisons were performed first for the entire study sample of preterm infants and
then for the subset of births following spontaneous preterm labor or PPROM. Because compli-
cations leading to very preterm delivery can influence neonatal and long-term outcomes
[23,24], we chose to study specifically the subgroup of spontaneous preterm births and
PPROM. This context of birth is both the most frequent situation faced by obstetricians and a
more homogenous group. All comparisons used the chi-square test.
Multivariate analyses using multiple logistic regression models were conducted to estimate
the relation of fetal presentation to neonatal mortality and to neurodevelopmental outcomes.
Adjusted ORs (adjORs) and 95% confidence intervals (CIs) were calculated adjusting first for
gestational age (the main risk factor), sex, and antenatal corticosteroid use (also known risk
factors for neonatal mortality and morbidity) [14,25], then adding SGA and PPROM, and
thirdly, maternity unit level and mode of delivery, which are also suggested risk factors.[19,26]
Because of the influence of social environment on cognitive development, analyses for cogni-
tive deficiencies were further adjusted for parental SES, maternal age at delivery, and maternal
country of birth. Statistical analyses were performed with SAS (SAS Institute Inc., Cary, NC),
version 9.3. All tests were two-sided, and the level of significance was P<0.05.
Results
After exclusion of 80 infants with severe congenital malformations (4.0% in the group of vertex
presentation versus 5.4% in the group of breech presentation, P = 0.23) and infants with non-
vertex and non-breech (n = 63) or unknown presentations (n = 109), this analysis included
1518 singleton infants alive at the beginning of preterm labor or before a cesarean delivery per-
formed before labor at 27 to 32 weeks of gestational age (Fig 1). Among them, 1392 were alive
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at discharge; 41 were not included in the follow-up, i.e., half the infants born at 32 weeks in two
regions, according to the initial protocol,[14] 65 families refused to participate in the follow-
up, 14 children died between hospital discharge and the age of 8 years, and 84 were completely
lost to follow-up (Fig 1). Finally, of the 1337 (1351–14) survivors at the age of 8 years,
Table 1. Classification of deficiencies. (1) [22]
Neuromotor deﬁciencies
Severe CP CP, unable to walk or walking only with aid at 8 or 5 years, or 2 years if no
further follow-up.
Moderate CP CP, walking without aid at 8 or 5 years, or 2 years if no further follow-up.
No CP, other motor
disorder
No CP but MND2 at Touwen examination (2) at age 5 years
or dyspraxia or motor coordination disorder (ICD F82, R26, R27) at 8 or 5 years,
or 2 years if no further follow-up.
None identiﬁed No CP and no other motor disorder identiﬁed (3).
Cognitive deﬁciencies/learning disabilities
Severe Mental retardation at 8 or 5 years (ICD F70-F79)
or special school/class (4) at 8 years with MPC at 5 years <70 (5)
or no information at 8 years but MPC at 5 years <70
or mental retardation at 2 years, if no further follow-up.
Moderate Moderate/mild cognitive deﬁciency mentioned in MDPH(6) record with no other
details,
or if in a mainstream class at 8 but having repeated one grade and/or receiving/
needing special support at school (4)
or no information at 8 years, MPC between 70 and 84 at 5 years.
None identiﬁed Mainstream class appropriate for age without any special support at 8 years
or if no information at 8 years, MPC>85 at 5 years
or if only medical examination at 2 or 5 years, no cognitive deﬁciency mentioned.
Overall deﬁciencies
Severe At least one of: severe CP, severe cognitive deﬁciency/learning disabilities,
severe psychiatric disorder,(7) epilepsy, visual deﬁciency or hearing deﬁciency.
Moderate At least one of: moderate CP, other motor disorder, moderate cognitive
deﬁciency
or moderate psychiatric disorder(8).
None identiﬁed None of the above.
(1) For each deﬁciency, the classiﬁcation follows a priority order according to severity at the most recent
step of the follow-up available.
(2) Having Moderate Neuromotor Dysfunction (MND-2) at the short version of the Touwen neurological
examination at the age of 5 years.19
(3) Including children without CP or other neuromotor disorders but who had not been assessed with the
Touwen examination.
(4) Except for visual or hearing deﬁciency only. Visual deﬁciency: blindness (uni-or bilateral) or Rossano
test 2 in both eyes at 5 years; Hearing deﬁciency: deafness in one or both ears or use of hearing aid at
any age.
(5) MPC = Mental Processing Composite of the Kaufman Assessment Battery for Children.20
(6) Maison Départementale des Personnes Handicapées (local ofﬁce for people with disabilities).
(7) Autism, pervasive development disorders (ICD F84) at 8 or 5 years.
(8) Hyperactivity or attention deﬁcit disorder (ICD F90) or conduct disorder (ICD F91) as a reason for a visit
to a psychiatrist or a psychologist at 8 or 5 years.
doi:10.1371/journal.pone.0145768.t001
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information on deficiencies was available for 1188 children (89%), the last point of follow-up
being the age of 2 years for 98 children, the age of 5 years for 249 and, and the age of 8 for 841.
Mothers of the 149 (65+84) children lost to follow-up were more frequently younger than
25 years, multiparous, and more often had a lower SES, lower educational level, and a national-
ity other than French (data not shown). Presentation, antenatal corticosteroid administration,
mode of delivery, gestational age at delivery, infant sex, and neonatal complications did not dif-
fer according to follow-up. However, among those born at 27–28 weeks of gestation, there was
a trend (not statistically significant) for more lost to follow-up among those born in vertex pre-
sentation than among those born in breech presentation.
Of the 1518 fetuses alive before delivery with known presentation and without any severe
congenital malformation, 351 (23.1%) were in breech presentation. Mothers of infants in
breech presentation were significantly older than those of infants in vertex presentation. The
groups did not differ for social characteristics (Table 2).
Fig 1. Study group. This figure is a flow chart describing the members of the EPIPAGE cohort included in
this study. (1) In two regions, the protocol planned to include only half of the children born at 32 weeks in the
follow-up.
doi:10.1371/journal.pone.0145768.g001
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Complications of pregnancy leading to the preterm birth were slightly but not significantly
different, with fewer vascular complications among the breech presentations (Table 2). Overall
the most common context of preterm delivery was spontaneous onset of labor or PPROM
(n = 871, 57.4%). Breech deliveries occurred more frequently in level 3 maternity units, more
often by cesarean section, and at earlier gestational ages. The same differences in mode of deliv-
ery and gestational age were observed when the analysis was restricted to the subset of mothers
with spontaneous preterm labor or PPROM only (Table 3).
Table 2. Maternal and pregnancy characteristics.
Vertex Breech
n % n % p
N 1167 351
Maternal age at birth (years)
<25 334 28.8 74 21.3 0.01
25–34 660 56.9 211 60.6
35 166 14.3 63 18.1
Parents’ socioeconomic status(1)
Professional 115 10.4 45 14.1 0.42
Intermediate 240 21.7 73 22.8
Administrative, public service, self-employed, students 255 23.1 69 21.6
Sales workers, service workers 191 17.3 52 16.3
Manual workers, unemployed 303 27.4 81 25.3
Mother’s educational level
No school or primary school only 78 7.5 24 7.7 0.78
Middle school 490 46.9 145 46.8
High school 206 19.7 68 21.9
University 270 25.9 73 23.5
Country of birth
Other than France 162 15.1 52 16.2 0.65
France 908 84.9 269 83.8
Parity
0 588 50.5 157 44.7 0.08
1 431 37.0 153 43.6
2 145 12.5 41 11.7
Previous cesarean section
No 1040 89.1 306 87.2 0.32
Yes 127 10.9 45 12.8
Complication of pregnancy
Maternal hypertension or SGA(2) 380 32.6 96 27.4 0.10
Spontaneous preterm labor or PPROM(3), without hypertension or SGA 663 56.8 208 59.3
Placenta previa, placental abruption, or other hemorrhage 60 5.1 28 8.0
Other 64 5.5 19 5.4
(1) SGA: small for gestational age (deﬁned as birth weight 10th percentile—EPIPAGE internal reference)–SGA were by deﬁnition excluded from the sub
group spontaneous preterm or PPROM
(2) EPIPAGE internal reference
(3) PPROM: Preterm premature rupture of membranes
doi:10.1371/journal.pone.0145768.t002
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Overall, neonatal mortality was significantly higher among infants in breech than vertex
presentation (10.8% vs. 7.5%, P = 0.05). The difference was larger in the subset of infants born
after spontaneous preterm labor or PPROM (13.0% vs.7.1%, P = 0.008) (Table 4).
The differences were no longer significant, however, after we controlled for gestational age
and other potential confounders (Table 5). Mortality after discharge was low (1%) and did not
differ according to fetal presentation (Table 4). The groups did not differ significantly for neo-
natal morbidity (Table 4). Severe cerebral palsy seemed to be less frequent in the breech group
(Table 4), but there was no significant difference after adjustment (Table 5). There was no dif-
ference according to presentation for cognitive deficiencies/learning disabilities or overall defi-
ciencies (Tables 4–5).
Table 3. Obstetric context according to fetal presentation.
Total Spontaneous preterm labor or
PPROM
Vertex Breech Vertex Breech
n % n % p n % n % p
N 1167 76.9 351 23.1 663 76.1 208 23.9
Level of maternity unit
1 237 20.3 52 14.8 0.01 150 22.6 36 17.3 0.25
2 255 21.9 66 18.8 142 21.4 50 24
3 675 57.8 233 66.4 371 56 122 58.7
Antenatal corticosteroids
No 338 29.7 84 24.6 0.07 203 31.3 62 30.4 0.80
Yes 801 70.3 257 75.4 445 68.7 142 69.6
Mode of delivery
Cesarean section before labor 121 10.4 87 25.1 <0.001 103 15.6 80 38.8 <0.001
Cesarean section during labor 508 43.6 171 49.3 43 6.5 43 20.9
Vaginal delivery 537 46.1 89 25.6 516 77.9 83 40.3
Gestational age at delivery (weeks)
27–28 200 17.1 98 27.9 <0.001 123 18.6 63 30.3 <0.001
29–30 329 28.2 101 28.8 198 29.9 56 26.9
31–32 638 54.7 152 43.3 342 51.6 89 42.8
Sex
Male 640 54.8 171 48.9 0.05 377 56.9 109 52.4 0.26
Female 527 45.2 179 51.1 286 43.1 99 47.6
SGA(1)
No 1059 90.7 314 89.7 0.56
Yes 108 9.3 36 10.3
Birth weight(2)
<10th percentile 108 9.3 36 10.3 0.33 0 0 0 0 0.90
[10-20th [percentile 103 8.8 39 11.1 18 2.7 6 2.9
 20th percentile 956 81.9 275 78.6 645 97.3 202 97.1
(1) SGA: small for gestational age (deﬁned as birth weight 10th percentile—EPIPAGE internal reference)–SGA were by deﬁnition excluded from the sub
group spontaneous preterm or PPROM.
(2) EPIPAGE internal reference.
doi:10.1371/journal.pone.0145768.t003
Outcomes of Very Preterm Infants in Breech Presentation at Delivery
PLOS ONE | DOI:10.1371/journal.pone.0145768 January 8, 2016 8 / 14
Discussion
Main findings
The main finding of this study is that in very preterm deliveries, breech presentation, compared
with vertex, was not an independent risk factor for neonatal mortality or long-term neurologi-
cal deficiencies. Before adjustment, a difference in mortality according to presentation was
observed, especially when the analysis was restricted to infants delivered after spontaneous pre-
term labor or PPROM. However, as previously observed by Goodman et al in a retrospective
study designed to assess differences in outcomes between vertex and nonvertex presentations
in case of PPROM between 24 and 34 weeks’ gestation [17], gestational age at delivery in EPI-
PAGE was lower in the breech group. This difference in gestational age is likely to explain both
the higher crude neonatal mortality rate of breech infants in both studies and the disappear-
ance of this difference after adjustment for gestational age in our study.
The increased risk of severe CP in the group of infants in vertex presentation compared to
breech is of concern. However our study is a secondary analysis of Epipage data, and the cohort
was not designed to compare the incidence of cerebral palsy between breech and vertex fetus.
Numbers were small, especially for breech presentations. When severe and moderate CP were
considered together, there was no significant difference according to fetal presentation. For
both outcomes, we cannot completely rule out the possibility that the absence of statistical sig-
nificance for a small difference after adjustment may result from a lack of power. But the study
had a power of 98% to detect a risk of cerebral palsy multiplied by 2 and of 50% to detect a risk
of cerebral palsy multiplied by 1.5.
Strengths and limitations
Besides a long-term follow-up and the assessment of outcomes at 2, 5, and 8 years (school age),
the strengths of the EPIPAGE study are its prospective design, its geographical basis, and its
large sample size: 9 regions covering one third of the annual births in the country. As evidenced
by the rarity of publications on whether breech presentation is an independent risk factor for
adverse outcome among preterm infants, the question is difficult to address, especially because
the causes of the preterm delivery might well mask perinatal and long-term mortality and mor-
bidity related to the presentation. It thus requires large cohorts of infants born preterm with
known details about the immediate reason for preterm delivery and mode of delivery. It also
requires long-term follow-up of these preterm infants, as before school age, subtle deficiencies
leading to learning difficulties remain undetected. This study fulfills both requirements.
Although born in 1997, our cohort is nonetheless more recent than most other studies of
this question and thus more likely to reflect current obstetric and neonatal care practices.
Despite the changes since then, in-utero transfer, antenatal steroids, early surfactant adminis-
tration, and new ventilation techniques were widely used in France in 1997. While more recent
data would have been valuable, studies such as EPIPAGE 2 of preterm deliveries in 2011 [27]
would not allow information on outcome at school age before several years.
A limitation inherent to long-term cohort studies is the attrition bias: some families moved
and others never replied even though they did not explicitly decline to participate. This phe-
nomenon affects our cohort, but information about deficiencies is available for at least one fol-
low-up point for 89% of the children. This follow-up rate should be considered in light of the
large number of children included, the substantial geographical dispersion, and the mobility of
parents with young children. Nonetheless, this loss to follow-up can be associated with the
underestimation of unfavorable outcomes. This bias has been observed in previous studies,
where the children lost to follow-up had a higher rate of cerebral lesions at neonatal ultrasound
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Table 4. Mortality, neonatal morbidity, and long term neurodevelopmental outcome according to fetal presentation.
Total Spontaneous preterm labor or
PPROM
Vertex Breech Vertex Breech
n % n % p n % n % p
N 1167 351 663 208
Neonatal mortality
No 1079 92.5 313 89.2 0.05 616 92.9 181 87.0 0.008
Yes 88 7.5 38 10.8 47 7.1 27 13.0
Mortality between neonatal unit discharge and age of 8 years
No 1050 99.0 307 99.0 0.92 599 98.4 177 98.3 0.98
Yes 11 1.0 3 1.0 10 1.6 3 1.7
Early-onset sepsis (1)
No 1038 93.1 313 93.4 0.83 560 88.9 177 89.8 0.71
Yes 77 6.9 22 6.6 70 11.1 20 10.2
Late-onset neonatal infection (2)
No 825 73.4 236 70.9 0.36 498 77.6 146 74.5 0.37
Yes 299 26.6 97 29.1 144 22.4 50 25.5
Necrotizing enterocolitis
No 1084 96.7 328 97.6 0.39 619 96.7 194 98.0 0.36
Yes 37 3.3 8 2.4 21 3.3 4 2.0
Bronchopulmonary dysplasia (3)
No 1008 91.2 289 88.4 0.12 579 92.3 176 89.8 0.26
Yes 97 8.8 38 11.6 48 7.7 20 10.2
Neonatal cerebral lesion (4)
Major 69 6.3 19 5.8 0.91 47 7.5 16 8.3 0.92
Moderate 138 12.5 45 13.7 79 12.6 26 13.5
Minor 158 14.3 44 13.4 88 14 24 12.5
None 737 66.9 220 67.1 413 65.9 126 65.6
Neuromotor deﬁciencies (5)
Severe CP (6) 36 3.9 2 0.7 0.03 33 6.3 2 1.2 0.09
Moderate CP 52 5.4 15 5.6 32 5.9 12 7.9
No CP, other motor disorder 33 3.4 15 5.6 20 3.7 5 3.7
None identiﬁed 791 87.3 244 88.2 434 84.1 137 87.2
Cognitive deﬁciencies/learning disabilities (5)
Severe 53 5.9 24 8.7 0.20 29 5.5 16 9.8 0.16
Moderate 212 22.9 56 20.2 120 22.7 32 20.1
None identiﬁed 647 71.3 196 71.1 370 71.8 108 70.1
Overall deﬁciencies (5)
Severe 97 10.7 29 10.5 0.81 60 11.4 19 11.6 0.99
Moderate 251 27.0 69 25.1 134 25.3 39 25.0
None identiﬁed 564 62.4 178 64.5 325 63.3 98 63.4
(1) Deﬁned as conﬁrmed infection of maternal origin (vertically transmitted).
(2) Deﬁned as a postnatally acquired infection (horizontally acquired) treated with antibiotics for at least 7 days.
(3) 0xygen at 36 weeks.
(4) Cerebral lesions included major lesions (cystic periventricular leukomalacia or intraparenchymal hemorrhage), moderate lesions (intraventricular
hemorrhage (IVH) with primary ventricular dilation or ventricular dilatation or persistent echodensity), minor lesions (subependymal hemorrhage or IVH
without ventricular dilation) and no lesion.
(5) See also Table 1.
(6) CP: cerebral palsy.
doi:10.1371/journal.pone.0145768.t004
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scans and a lower SES [28]. In our study, the SES of families of children lost to follow-up was
lower than for those who continued to participate, but rates of neonatal cerebral lesions were
similar. The fact that children lost to follow-up were more likely to belong to families with a
lower SES raises concerns about the potential underestimation of cognitive deficiencies [29].
Furthermore, we were not able to assess the cognitive performance of the 98 children followed
only until the age of 2. However the proportion of children lost to follow up did not vary
according to presentation, and it is unlikely that it biased the comparison.
Interpretation
Most studies of preterm breech have focused on mode of delivery, and very few have been
designed to determine whether fetal presentation is an independent risk factor for adverse out-
comes [11,12]. Demol et al. did focus on neonatal mortality in preterm infants, comparing 692
non-vertex to 4685 vertex infants born between 1985 and 1995 [12]. In contrast with our
results, they reached the conclusion that breech presentation in preterm delivery is an
Table 5. Neonatal mortality and long term neurodevelopmental outcome according to fetal presentation, multivariate analyses.
Total Spontaneous preterm labor or PPROM
Breech vs vertex Breech vs vertex
N OR (95%CI) N OR (95%CI)
Neonatal mortality
Crude OR 1518 1.49 1.00–2.22 871 1.96 1.18–3.23
AdjOR1 1480 1.12 0.71–1.76 852 1.49 0.87–2.58
AdjOR2 1472 1.15 0.73–1.82 852 1.53 0.89–2.65
AdjOR3 1469 1.09 0.68–1.73 849 1.40 0.78–2.49
Neuromotor deﬁciencies(1)
Severe or moderate CP
Crude OR 1188 0.65 0.38–1.13 675 0.73 0.39–1.35
AdjOR1 1168 0.60 0.34–1.05 663 0.68 0.36–1.29
AdjOR2 1162 0.58 0.33–1.02 663 0.68 0.36–1.30
AdjOR3 1160 0.67 0.37–1.21 661 0.81 0.41–1.61
Cognitive deﬁciencies / learning disabilities (1)
Severe or moderate
Crude OR 1188 1.01 0.75–1.37 675 1.08 0.73–1.61
AdjOR1 1168 0.95 0.70–1.30 663 1.05 0.70–1.56
AdjOR2 1162 0.96 0.70–1.31 663 1.06 0.71–1.58
AdjOR4 1130 0.86 0.61–1.23 642 0.96 0.60–1.55
Overall deﬁciencies(1)
Severe or moderate
Crude OR 1188 0.91 0.69–1.22 675 0.99 0.68–1.45
AdjOR1 1168 0.86 0.64–1.16 663 0.96 0.65–1.41
AdjOR2 1162 0.88 0.65–1.18 663 0.99 0.67–1.45
AdjOR4 1130 0.85 0.62–1.17 642 1.02 0.66–1.58
adjOR1: adjusted for gestational age, sex, and antenatal corticosteroids. adjOR2: adjusted for gestational age, sex, antenatal corticosteroids, SGA, and
PPROM. adjOR3: adjusted for gestational age, sex, antenatal corticosteroids, SGA, PPROM, maternity unit level, and mode of delivery. adjOR4: adjusted
for gestational age, sex, antenatal corticosteroids, SGA, PPROM, maternity unit level, mode of delivery, parental socioeconomic status, maternal age at
delivery, and country of birth.
(1) See Table 1
doi:10.1371/journal.pone.0145768.t005
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independent risk factor for neonatal mortality (adjOR = 2.2 95%CI 1.37–3.57). No follow-up
data were available. Several factors may explain this difference with our results; (i) although the
gestational age of the infants included in their analysis ranged from 24 to 36 weeks, 79.6% of
their study population had a gestational age of 33 to 36 weeks and 5.6% between 24–27 weeks;
they thus differ quite substantially from our population aged 27–32 weeks of gestation; (ii)
their study was retrospective, whereas ours was prospective; (iii) severe congenital anomalies,
significantly more frequent in both nonvertex groups, were not excluded from their analysis
but were in ours. Our decision to exclude these infants was made for two reasons. First, previ-
ous reports indicated that an increased frequency of such anomalies could be expected in non-
vertex presentations. Although not significant, the same trend was observed in our cohort.
Second, a known congenital anomaly is likely to lead clinicians to approach management of
delivery and/or neonatal care with a somewhat different attitude.
Like us, Gravenhorst et al. also excluded congenital anomalies in their report of the Dutch
nation-wide study of very preterm or very low birth weight infants born in 1983 (POPS),[11]
and they observed an increased risk of neonatal mortality for breech compared to vertex
(adjOR = 1.6, P<0.05). However the inclusion of infants of very low birth weight of higher ges-
tational ages, may modify the results. At the age of 5, the adjusted risk of handicap in the two
groups did not differ.
Conclusion
In conclusion, our data suggest that breech presentation is not an independent risk factor for
neonatal mortality or long-term neuromotor or cognitive deficiencies for very preterm infants.
Our results can help physicians provide useful information to parents.
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